Preclinical Outsourcing
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
-
Analytical Services | CRO News | Industry News | Laboratory Testing | Preclinical Outsourcing
BASi, Seventh Wave Labs Merge
Will join operations in an effort to provide broader solutions and expanded scientific expertise07.02.18
-
Drug Discovery | Preclinical Outsourcing
Preclinical Partnerships
Bill Barbo of Charles River discusses drug discovery and outsourcing trends in today’s marketOnline Exclusives04.10.18
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Preclinical Outsourcing
Abzena Expands ADC Capabilities
Facility remodeling completed for new ADC GMP manufacturing suite03.27.18
-
Bioanalytical Services | Breaking News | Collaborations & Alliances | CRO News | Facilities | Industry News | Preclinical Outsourcing
Frontage Laboratories Opens Third NJ Location
New 4,500 sq. ft. space is located in Princeton03.13.18
-
Drug Development | Preclinical Outsourcing | R&D
Advancing Rare Disease Research
How early research provides the crucial evidence needed to conduct clinical trialsOnline Exclusives Kristin Brooks, Contract Pharma 03.05.18
-
Analytical Services | CRO News | Laboratory Testing | Preclinical Outsourcing | Toxicology
Charles River Pays $800M for MPI Research
Expands client base, service portfolio, and builds scale02.13.18
-
CRO News | Drug Discovery | Preclinical Outsourcing
Eurofins Scientific Acquires Selcia
Adds custom radiolabelling and preclinical, integrated drug discovery services01.25.18
-
Drug Development | Drug Discovery | Preclinical Outsourcing
Outsourcing Early Drug Development
Birgit Girshick of Charles River discusses trends in the early discovery and development spaceOnline Exclusives01.17.18
-
CRO News | Drug Discovery | Preclinical Outsourcing
Charles River Acquires KWS BioTest
Expands discovery services for immuno-oncology, inflammatory, and infectious diseases01.11.18
-
CRO News | Laboratory Testing | Preclinical Outsourcing
-
Collaborations & Alliances | Drug Discovery | Preclinical Outsourcing
Encycle, Pfizer Enter Nacellins Discovery Pact
Will partner to optimize certain nacellins that act on an undisclosed therapeutic target11.02.17
-
Collaborations & Alliances | Drug Discovery | Preclinical Outsourcing
BioMed X, Janssen in Preclinical R&D Alliance
Innovation Center in Heidelberg to foster Janssen's preclinical biomedical R&D projects10.26.17
-
CRO News | Drug Discovery | Preclinical Outsourcing
-
Bio News | Bioanalytical Services | Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
ABL Acquisition Extends Ardena’s Early-phase Offering
Broadens the CDMO’s pre-clinical and clinical offering to include bioanalytical and drug discovery services.10.10.17
-
Drug Development | Industry News | Preclinical Outsourcing
Medivir, BioAscent Enter Compound Management Pact
Will manage Medivir's compound collection of approximately 56,000 samples08.23.17
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News | Preclinical Outsourcing
Abzena and OBI Pharma Sign ThioBridge License Agreement
Master services and clinical supply agreement to enable process development and manufacturing by Abzena07.14.17
-
Bio News | Breaking News | Industry News | Preclinical Outsourcing | R&D
The Jackson Laboratory and Crown Bioscience Team Up
Form global pre-clinical research agreement06.26.17
-
Drug Development | Drug Discovery | Industry News | Preclinical Outsourcing
Almac Discovery, Debiopharm Enter Wee-1 Alliance
To develop Almac’s Wee-1 kinase inhibitor program06.21.17
-
Chemistry | Collaborations & Alliances | Drug Discovery | Preclinical Outsourcing
Aptuit, Regulus in Strategic Provider Pact
To provide a range of discovery, CMC and non-clinical services06.12.17
